News

The American Journal of Managed Care56m
Mepolizumab Reduces COPD Exacerbations in Patients With Eosinophilic Inflammation
New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of ...